Tumors of the skeletal system

Withrow & MacEwen's Small Animal Clinical Oncology

Volumn , Issue , 2007, Pages 540-582

  Dernell, William S ^a   Ehrhart, Nicole P ^a   Straw, Rodney C ^b,c,d   Vail, David M ^e  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b Brisbane Veterinary Specialist Centre   (Australia)

^c Animal Cancer Care ^*  (United States)

^d Australian Animal Cancer Foundation Limited   (Australia)

^e UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84860337939     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-072160558-6.50026-5     Document Type: Chapter

References (369)

1. Brodey RS, Riser WH Canine osteosarcoma: a clinicopathological study of 194 cases. Clin Orthop 1969, 62:54-64.
2. Ling GV, Morgan JP, Pool RR Primary bone tumors in the dog: a combined clinical, radiological, and histologic approach to early diagnosis. J Am Vet Med Assoc 1974, 165:55-67.
3. Lui SK, Dorfman HD, Hurvitz AI, et al. Primary and secondary bone tumors in the dog. J Am Vet Med Assoc 1977, 18:313-326.
4. Brodey RS, Sauer RM, Medway W Canine bone neoplasms. J Am Vet Med Assoc 1963, 143:471-495.
5. Brodey RS, McGrath JT, Reynolds H A clinical and radiological study of canine bone neoplasms: part I. J Am Vet Med Assoc 1959, 134:53-71.
6. Priester WA, ed: The occurrence of tumors in domestic animals, NCI Monogr No. 54, November 1980.
7. Withrow SJ, Powers BE, Straw RC, et al. Comparative aspects of osteosarcoma: dog vs. man. Clin Orthop 1991, 270:159-167.
8. Brodey RS, Abt DA Results of surgical treatment in 65 dogs with osteosarcoma. J Am Vet Med Assoc 1976, 168:1032-1035.
9. Smith RL, Sutton RH Osteosarcoma in dogs in the Brisbane area. Aust Vet Pract 1988, 18:97-100.
10. Tjalma RA Canine bone sarcoma: estimation of relative risk as a function of body size. J Natl Cancer Inst 1966, 36:1137-1150.
11. Misdorp W, Hart AA Some prognostic and epidemiological factors in canine osteosarcoma. J Natl Cancer Inst 1979, 62:537-545.
12. Wolke RE, Nielsen SW Site incidence of canine osteosarcoma. J Small Anim Pract 1966, 7:489-492.
13. Spodnick GJ, Berg RJ, Rand WM, et al. Prognosis for dogs with appendicular osteosarcoma treated by amputation alone: 162 cases (1978-1988). J Am Vet Med Assoc 1992, 200:995-999.
14. Straw RC, Withrow SJ, Richter SL, et al. Amputation and cisplatin for treatment of canine osteosarcoma. J Vet Int Med 1991, 5:205-210.
15. Misdorp W Skeletal osteosarcoma. Am J Path 1980, 98:285-288.
16. Knecht CD, Priester WA Musculoskeletal tumors in dogs. J Am Vet Med Assoc 1978, 172:72-74.
17. Straw RC Tumors of the skeletal system. Clinical veterinary oncology 1996, WB Saunders, Philadelphia. S.J. Withrow, E.G. MacEwen (Eds.).
18. Goldschmidt MH, Thrall DE Malignant bone tumors in the dog. Textbook of small animal orthopedics 1985, JB Lippincott, Philadelphia. C.D. Newton, D.M. Nunamaker (Eds.).
19. Owen LN Bone tumors in man and animals 1969, Butterworth & Co, London.
20. Alexander JW, Patton CS Primary tumors of the skeletal system. Vet Clin North Am 1983, 13:181-195.
21. Jongeward SJ Primary bone tumors. Vet Clin North Am 1985, 15:609-641.
22. Nielsen SW, Schroder JD, Smith DTL The pathology of osteogenic sarcoma in dogs. J Am Vet Med Assoc 1954, 124:28-35.
23. Kistler KR: Canine osteosarcoma: 1462 cases reviewed to uncover patterns of height, weight, breed, sex, age and site involvement. Phi Zeta Awards, University of Pennsylvania, School of Veterinary Medicine, 1981.
24. Riser WH Bone tumors in the dog. Vet Annual 1976, 16:147-150.
25. Phillips L, Hagar H, Parker R, et al. Osteosarcoma with a pathological fracture in a six-month-old dog. Vet Radiol 1986, 27:18-19.
26. Heyman SJ, Diefenderfer DL, Goldschmidt MH, et al. Canine axial skeletal osteosarcoma a retrospective study of 116 cases (1986-1989). Vet Surg 1992, 21:304-310.
27. Feeney DA, Johnston GR, Grindem CB Malignant neoplasia of canine ribs: clinical, radiological, and pathological findings. J Am Vet Med Assoc 1982, 180:927-933.
28. Ru G, Terracini B, Glickman LT Host related risk factors for canine osteosarcoma. Vet J 1998, 156:31-39.
29. Cooley DM, Beranek BC, Schlittler DL, et al. Endogenous gonadal hormone exposure and bone sarcoma risk. Cancer Epidemiol Biomarkers Prev 2002, 11:1434-1440.
30. Liptak JM, Dernell WS, Straw RC, et al. Proximal radial and distal humeral osteosarcoma in 12 dogs. J Am Anim Hosp Assoc 2004, 40:461-467.
31. Gamblin RM, Straw RC, Powers BE, et al. Primary osteosarcoma distal to the antebrachiocarpal and tarsocrural joints in nine dogs (1980-1992). J Am Anim Hosp Assoc 1995, 31:86-91.
32. Bleier T, Lewitschek HP, Reinacher M Canine osteosarcoma of the penile bone. J Vet Med A Physiol Pathol Clin Med 2003, 50:397-398.
33. Lucroy MD, Peck JN, Berry CR Osteosarcoma of the patella with pulmonary metastases in a dog. Vet Radiol Ultrasound 2001, 42:218-220.
34. LaRue SM, Withrow SJ, Wrigley RH Radiographic bone surveys in the evaluation of primary bone tumors in dogs. J Am Vet Med Assoc 1986, 188:514-516.
35. Thamm DH, Mauldin EA, Edinger DT, et al. Primary osteosarcoma of the synovium in a dog. J Am Anim Hosp Assoc 2000, 36:326-331.
36. Ringenberg MA, Neitzel LE, Zachary JF Meningeal osteosarcoma in a dog. Vet Pathol 2000, 37:653-655.
37. Bech-Nielsen S, Haskins ME, Reif JS, et al. Frequency of osteosarcoma among first-degree relatives of St. Bernard dogs. J Natl Cancer Inst 1978, 60:349-353.
38. Kuntz CA, Dernell WS, Powers BE, et al. Extraskeletal osteosarcomas in dogs:14 cases. J Am Anim Hosp Assoc 1998, 34:26-30.
39. Langenbach A, Anderson MA, Dambach DM, et al. Extraskeletal osteosarcomas in dogs: a retrospective study of 169 cases (1986-1996). J Am Anim Hosp Assoc 1998, 34:113-120.
40. Patnaik AK Canine extraskeletal osteosarcoma and chondrosarcoma: a clinicopathological study of 14 cases. Vet Pathol 1990, 27:46-55.
41. Owen LN Transplantation of canine osteosarcoma. Eur J Cancer 1969, 5:615-620.
42. Gellasch KL, Kalscheur VL, Clayton MK, et al. Fatigue microdamage in the radial predilection site for osteosarcoma in dogs. Am J Vet Res 2002, 63:896-899.
43. Rosin A, Rowland GN Undifferentiated sarcoma in a dog following chronic irritation by a metallic foreign body and concurrent infection. J Am Anim Hosp Assoc 1981, 17:593-598.
44. Bennett D, Campbell JR, Brown P Osteosarcoma associated with healed fractures. J Small Anim Pract 1979, 20:13-18.
45. Stevenson S, Holm RB, Pohler OEM, et al. Fracture-associated sarcoma in the dog. J Am Vet Med Assoc 1982, 180:1189.
46. Sinibaldi K, Rosen H, Liu S, et al. Tumors associated with metallic implants in animals. Clin Orthop 1976, 118:257-266.
47. Knecht CD, Priester WA Osteosarcoma in dogs: a study of previous trauma, fracture and fracture fixation, J. Am Anim Hosp Assoc 1978, 14:82-84.
48. Vasseur PB, Stevenson S Osteosarcoma at the site of a cortical bone allograft in a dog. Vet Surg 1987, 16:70-74.
49. Miller SC, Lloyd RD, Bruenger FW, et al. Comparisons of the skeletal locations of putative plutonium-induced osteosarcomas in humans with those in beagle dogs and with naturally occurring tumors in both species. Radiat Res 2003, 160:517-523.
50. Lloyd RD, Taylor GN, Angus W, et al. Distribution of skeletal malignancies in beagles injected with 239Pu citrate. Health Phys 1994, 66:407-413.
51. White RG, Raabe OG, Culbertson MR, et al. Bone sarcoma characteristics and distribution in beagles injected with radium-226. Radiat Res 1994, 137:361-370.
52. White RG, Raabe OG, Culbertson MR, et al. Bone sarcoma characteristics and distribution in beagles fed strontium-90. Radiat Res 1993, 136:178-189.
53. McChesney-Gillette S, Gillette EL, Powers BE, et al. Radiation-induced osteosarcoma in dogs after external beam or intraoperative radiation therapy. Cancer Res 1990, 50:54-57.
54. Powers BE, Gillette EL, McChesney SL, et al. Bone necrosis and tumor induction following experimental intraoperative irradiation. Int J Radiat Oncol Biol Phys 1989, 17:559-567.
55. McEntee MC, Page RL, Theon A, et al. Malignant tumor formation in dogs previously irradiated for acanthomatous epulis. Vet Radiol Ultrasound 2004, 45:357-361.
56. Tillotson C, Rosenberg A, Gebhardt M, et al. Postradiation multicentric osteosarcoma. Cancer 1988, 62:67-71.
57. Robinson E, Neugut AI, Wylie P Clinical aspects of postirradiation sarcomas. J Natl Cancer Inst 1988, 80:233-240.
58. McKenna RJ, Schwinn CP, Soong KY, et al. Sarcomata of the osteogenic series (osteosarcoma, fibrosarcoma, chondrosarcoma, parosteal osteogenic sarcoma, and sarcomata arising in abnormal bone): an analysis of 552 cases. J Bone Joint Surg 1966, 48A:1-26.
59. Dahlin DC, Coventry MB Osteogenic sarcoma: a study of 600 cases. J Bone Joint Surg 1967, 49A:101-110.
60. Dubielzig TF, Biery DN, Brodey RS Bone sarcomas associated with multifocal medullary bone infarction in dogs. J Am Vet Med Assoc 1981, 179:64-68.
61. Prior C, Watrous BJ, Penfold D Radial diaphyseal osteosarcoma with associated bone infarction in a dog. J Am Anim Hosp Assoc 1986, 22:43-48.
62. Ansari MM Bone infarcts associated with malignant sarcomas. Comp Cont Ed Pract Vet 1991, 3:367-370.
63. Marcellin-Little DJ, DeYoung DJ, Thrall DE, et al. Osteosarcoma at the site of bone infarction associated with total hip arthroplasty in a dog. Vet Surg 1999, 28:54-60.
64. Holmberg BJ, Farese JP, Taylor D, et al. Osteosarcoma of the humeral head associated with osteochondritis dissecans in a dog. J Am Anim Hosp Assoc 2004, 40:246-249.
65. Barnhart MD Malignant transformation of an aneurismal bone cyst in a dog. Vet Surg 2002, 31:519-524.
66. Hansen WH Molecular genetic considerations in osteosarcoma. Clin Orthop 1991, 270:237-246.
67. Meyer WH Recent developments in genetic mechanisms, assessment, and treatment of osteosarcomas. Curr Opin Oncol 1991, 3:689-693.
68. Yamaguchi T, Toguchida J, Yamamuro T, et al. Allelotype analysis in osteosarcomas: frequent allele loss on 3q, 13q, 17p, and 18q. Cancer Res 1992, 52:2419-2423.
69. Araki N, Uchida A, Kimura T, et al. Involvement of the retinoblastoma gene in primary osteosarcomas and other bone and soft tissue tumors. Clin Orthop 1991, 270:271-277.
70. Strauss PG, Mitreiter K, Zitzelsberger H, et al. Elevated p53 RNA expression correlates with incomplete osteogenic differentiation of radiation-induced murine osteosarcomas. Int J Cancer 1992, 50:252-258.
71. Toguchida T, Yamaguchi T, Dayton SH, et al. Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma. N Engl J Med 1992, 326:1301-1308.
72. Chandar N, Billig B, McMaster J, et al. Inactivation of p53 gene in human and murine osteosarcoma cells. Br J Cancer 1992, 65:208-214.
73. McIntyre JF, Smith-Sorensen B, Friend SH, et al. Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma. J Clin Oncol 1994, 12:925-930.
74. Sagartz JE, Bodley WL, Gamblin RM, et al. p53 Tumor Suppressor Protein Overexpression in Osteogenic Tumors of Dogs. Vet Pathol 1996, 33:213-221.
75. Mendoza S, Konishi T, Dernell WS, et al. Status of the p53, Rb and Mdm2 genes in canine osteosarcoma. Anticancer Res 1998, 18:4449-4454.
76. Levine RA, Fleischli MA Inactivation of p53 and retinoblastoma family pathways in canine osteosarcoma cell lines. Vet Path 2000, 37:54-61.
77. Johnson AS, Couto CG, Weghorst CM Mutation of the p53 tumor suppressor gene in spontaneously occurring osteosarcomas of the dog. Carcinogenesis 1998, 19:213-217.
78. Setoguchi A, Sakai T, Okuda M, et al. Aberrations of the p53 tumor suppressor gene in various tumors in dogs. Am J Vet Res 2001, 62:433-439.
79. Yazawa M, Setoguchi A, Hong SH, et al. Effect of an adenoviral vector that expresses the canine p53 gene on cell growth of canine osteosarcoma and mammary adenocarcinoma cell lines. Am J Vet Res 2003, 64:880-888.
80. Loukopoulos P, Thornton JR, Robinson WF Clinical and pathologic relevance of p53 index in canine osseous tumors. Vet Pathol 2003, 40:237-248.
81. Kirpensteijn J, Timmermans-Sprang EP, Van Garderen E, et al. Growth hormone gene expression in canine normal growth plates and spontaneous osteosarcoma. Mol Cell Endocrinol 2002, 197:179-185.
82. MacEwen EG, Pastor J, Kutze J, et al. IGF-1 receptor contributes to the malignant phenotype in human and canine osteosarcoma. J Cell Biochem 2004, 92:77-91.
83. MacEwen E, Kutzke J, Carew J, et al. c-Met tyrosine kinase receptor expression and function in human and canine osteosarcoma cells. Clin Exp Metastasis 2003, 20:421-430.
84. Liao ATR, McMahon M, London C Characterization, expression and function of c-Met in canine spontaneous cancers. Vet Comp Oncol 2005, 3:61-72.
85. Ferracini R, Angelini P, Cagliero E, et al. Met oncogene aberrant expression in canine osteosarcoma. J Orthop Res 2000, 18:253-256.
86. Flint AF, U'Ren L, Legare ME, et al. Overexpression of the erbB-2 proto-oncogene in canine osteosarcoma cell lines and tumors. Vet Pathol 2004, 41:291-296.
87. Maitra A, Wanzer D, Weinberg AG, et al. Amplification of the HER-2/neu oncogene is uncommon in pediatric osteosarcomas. Cancer 2001, 92:677-683.
88. Levine RA, Forest T, Smith C Tumor suppressor PTEN is mutated in canine osteosarcoma cell lines and Tumors. Vet Pathol 2002, 39:372-378.
89. Levine RA Overexpression of the sis oncogene in a canine osteosarcoma cell line. Vet Pathol 2002, 39:411-412.
90. Jones CL, Grahn RA, Chien MB, et al. Detection of c-kit mutations in canine mast cell tumors using fluorescent polyacrylamide gel electrophoresis. J Vet Diagn Invest 2004, 16:95-100.
91. Entz-Werle N, Marcellin L, Gaui L-M, et al. Prognostic significance of alleleic imbalance at the c-kit gene locus and c-kit overexpression by immunohistochemistry in pediatric osteosarcomas. J Clin Oncol 2005, 23:2248-2255.
92. Pryer NK, Lee LB, Zadovaskaya R, et al. Proof of target for SU11654: inhibition of KIT phosphorylation in canine mast cell tumors. Clin Cancer Res 2003, 9:5729-5734.
93. Loukopoulos P, O'Brien T, Ghoddusi M, et al. Characterization of three novel canine osteosarcoma cell lines producing high levels of matrix metalloproteinases. Res Vet Sci 2004, 77:131-141.
94. Lana SE, Ogilvie GK, Hansen RA, et al. Identification of matrix metalloproteinases in canine neoplastic tissue. Am J Vet Res 2000, 61:111-114.
95. Khanna C, Wan X, Bose S, et al. The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat Med 2004, 10:182-186. Epub 2004 Jan 4.
96. Mullins MN, Lana SE, Dernell WS, et al. Cyclooxygenase-2 expression in canine appendicular osteosarcomas. J Vet Intern Med 2004, 1:859-865.
97. Mohammed SI, Khan KN, Sellers RS, et al. Expression of cyclooxygenase-1 and 2 in naturally-occurring canine cancer. Prostaglandins Leukot Essent Fatty Acids 2004, 70:479-483.
98. Coomber BL, Denton J, Sylvestre A, et al. Blood vessel density in canine osteosarcoma. Can J Vet Res 1998, 62:199-204.
99. DiResta GR, Aiken SW, Healey J Dog osteogenic sarcoma microvasculature observed with a Spalteholz technique. Clin Orthop Relat Res 2004, 426:39-43.
100. Wergin MC, Kaser-Hotz B Plasma vascular endothelial growth factor (VEGF) measured in seventy dogs with spontaneously occurring tumours. In Vivo 2004, 18:15-19.
101. Pirie-Shepherd SR, Coffman KT, Resnick D, et al. The role of angiostatin in the spontaneous bone and prostate cancers of pet dogs. Biochem Biophys Res Commun 2002, 292:886-891.
102. Ohta G, Sakai H, Kachi S, et al. Assessment of proliferative potentials of canine osteosarcomas and chondrosarcomas by MIB-1 immunohistochemistry and bromodeoxyuridine incorporation. J Comp Pathol 2004, 131:18-27.
103. Hong SH, Ohashi E, Kadosawa T, et al. Retinoid receptors and the induction of apoptosis in canine osteosarcoma cells. J Vet Med Sci 2000, 62:469-472.
104. Hong SH, Kadosawa T, Nozaki K, et al. In vitro retinoid-induced growth inhibition and morphologic differentiation of canine osteosarcoma cells. Am J Vet Res 2000, 61:69-73.
105. Ashton JA, Farese JP, Milner RJ, et al. Investigation of the effect of pamidronate disodium on the in vitro viability of osteosarcoma cells from dogs. Am J Vet Res 2005, 66:885-891.
106. Farese JP, Ashton J, Milner R, et al. The effect of the bisphosphonate alendronate on viability of canine osteosarcoma cells in vitro. In Vitro Cell Dev Biol Anim 2004, 40:113-117.
107. Poirier VJ, Huelsmeyer MK, Kurzman ID, et al. The bisphosphonates alendronate and zoledronate are inhibitors of canine and human osteosarcoma cell growth. in vitro, Vet Compar Oncol 2003, 1:207-215.
108. Yazawa M, Okuda M, Kanaya N, et al. Molecular cloning of the canine telomerase reverse transcriptase gene and its expression in neoplastic and non-neoplastic cells. Am J Vet Res 2003, 64:1395-1400.
109. Mertens F, Mandahl N, Orndal C, et al. Cytogenetic findings in 33 osteosarcomas. Int J Cancer 1993, 55:44-50.
110. Khanna C, Kahn J, Nguyen P, et al. Metastasis-associated differences in gene expression in a murine model of osteosarcoma. Cancer Res 2001, 61:3750-3759.
111. Sotiriou C, Khanna C, Jazaeri AA, et al. Core biopsies can be used to distinguish differences in expression profiling by cDNA microarrays, J. Mol Diagn 2002, 4:30-36.
112. Mintz MB, Sowers R, Brown KM, et al. An expression signature classifies chemotherapy-resistant pediatric osteosarcoma. Cancer Res 2005, 65:1748-1754.
113. Dillberger J: Osteosarcoma genetic screening project achieves a milestone. Caber Feidh Scottish Deerhound website 7/1/ 2004.
114. Barger A, Grace R, Bailey K, et al. Use of alkaline phosphatase staining to differentiate canine osteosarcoma from other vimentin-positive tumors. Vet Pathol 2005, 42:161-165.
115. Kirpensteijn J, Kik M., Rutterman GR, et al. Prognostic significance of a new histologic grading system for canine osteosarcoma. Vet Pathol 2002, 39:240-246.
116. Fox MH, Armstrong LW, Withrow SJ, et al. Comparison of DNA aneuploidy of primary and metastatic spontaneous canine osteosarcomas. Cancer Res 1990, 50:6176-6178.
117. Brem H, Folkman J Inhibition of tumor angiogenesis mediated by cartilage. J Exp Med 1975, 141:427-434.
118. Kuettner KE, Pauli BU, Soble L Morphological studies on the resistance of cartilage to invasion by osteosarcoma cells in vitro and in vivo. Cancer Res 1978, 38:277-282.
119. Hillers KR, Dernell WS, Lafferty MHI, et al. Incidence and prognostic importance of lymph node metastases in dogs with appendicular osteosarcoma: 228 cases (1986-2003). J Am Vet Med Assoc 2005, 226:1364-1367.
120. Bacci G, Avella M, Picci P Metastatic patterns in osteosarcoma. Tumori 1988, 74:421-427.
121. Campanacci M, Bacci G, Bertoni F Treatment of osteosarcoma of the extremities. Cancer 1981, 48:1569-1581.
122. Giuliano AE, Feig S, Eilber FR Changing metastatic patterns of osteosarcoma. Cancer 1984, 54:2160-2164.
123. Huth JF, Eilber FR Patterns of recurrence after resection of osteosarcoma of the extremity: strategies for treatment of metastasis. Arch Surg 1989, 124:122-126.
124. Moore GE, Mathey WS, Eggers JS, et al. Osteosarcoma in adjacent lumbar vertebrae in a dog. J Am Vet Med Assoc 2000, 217:1038-1040.
125. Dickerson ME, Page RL, LaDue TA, et al. Retrospective analysis of axial skeleton osteosarcoma in 22 large breed dogs. J Vet Int Med 2001, 15:120-124.
126. Straw RC, Powers BE, Klausner J, et al. Canine mandibular osteosarcoma: 51 cases (1980-1992). J Am Anim Hosp Assoc 1996, 32:257-262.
127. Mehl ML, Withrow SJ, Seguin B, et al. Spontaneous regression of osteosarcoma in four dogs. J Am Vet Med Assoc 2001, 219:614-617.
128. Boulay JP, Wallace LJ, Lipowitz AJ Pathologic fracture of long bones in the dog. J Am Anim Hosp Assoc 1987, 23:297-303.
129. Mazzaferro EM, Hackett TB, Stein TP, et al. Metabolic alterations in dogs with osteosarcoma. Am J Vet Res 2001, 62:1234-1239.
130. Kazmierski KJ, Ogilvie GK, Fettman MJ, et al. Serum zinc, chromium, and iron concentrations in dogs with lymphoma and osteosarcoma. J Vet Intern Med 2001, 15:585-588.
131. Thrall DE Bone tumors versus bone infections. Textbook of veterinary diagnostic radiology 1998, W.B. Saunders, Philadelphia. D.E. Thrall (Ed.).
132. Legendre AM Blastomycosis. Infectious diseases of the dog and cat 1990, W.B. Saunders, Philadelphia. C.G. Greene (Ed.).
133. Barsanti JA, Jeffery KL Coccidioidomycosis. Infectious diseases of the dog and cat 1990, W.B. Saunders, Philadelphia. C.E. Greene (Ed.).
134. Neer M Disseminated aspergillosis. Comp Contin Educ Pract Vet 1988, 10:465-471.
135. Samii VF, Nyland TG, Werner LL, et al. Ultrasound-guided fine-needle aspiration biopsy of bone lesions: a preliminary report. Vet Radiol Ultrasound 1999, 40:82-86.
136. Reinhardt S, Stockhaus C, Teske E, et al. Assessment of cytological criteria for diagnosing osteosarcoma in dogs. J Small Anim Pract 2005, 46:65-70.
137. Ehrhart N Principles of tumor biopsy. Clin Technique Small Anim Pract 1998, 13:10-16.
138. Mankin HJ, Lange TA, Spanier SS The hazards of biopsy in patients with malignant bone and soft-tissue tumors. J Bone Joint Surg 1982, 64A:1121-1127.
139. DeSantos LA, Murray JA, Ayala AG The value of percutaneous needle biopsy in the management of primary bone tumors. Cancer 1979, 43:735-744.
140. Simon MA Current concepts review, biopsy of musculoskeletal tumors. J Bone Joint Surg 1982, 64-A:1253-1257.
141. Wykes PM, Withrow SJ, Powers BE Closed biopsy for diagnosis of long bone tumors: accuracy and results. J Am Anim Hosp Assoc 1985, 21:489-494.
142. Powers BE, LaRue SM, Withrow SJ, et al. Jamshidi needle biopsy for diagnosis of bone lesions in small animals. J Am Vet Med Assoc 1988, 193:205-210.
143. Vignoli M, Ohlerth S, Rossi F, et al. Computed tomography-guided fine-needle aspiration and tissue core biopsy of bone lesions in small animals. Vet Radiol Ultrasound 2004, 45:125-130.
144. Barthez PY, Hornof WJ, Theon AP, et al. Receiver operating characteristic curve analysis of the performance of various radiographic protocols when screening dogs for pulmonary metastases. J Am Vet Med Assoc 1994, 204:237-240.
145. Waters DJ, Coakley FV, Cohen MD, et al. The detection of pulmonary metastases by helical CT: a clinicopathologic study in dogs. J Comput Assist Tomogr 1998, 22:235-240.
146. Picci P, Vanel D, Briccoli A, et al. Computed tomography of pulmonary metastases from osteosarcoma: the less poor technique: a study of 51 patients with histological correlation. Annals Oncol 2001, 12:1601-1604.
147. Straw RC, Cook NL, LaRue SM, et al. Radiographic bone surveys. J Am Vet Med Assoc 1989, 195(letters):1458.
148. Lamb CR Bone scintigraphy in small animals. J Am Vet Med Assoc 1987, 191:1616-1622.
149. Hahn KA, Hurd C, Cantwell HD Single-phase methylene diphosphate bone scintigraphy in the diagnostic evaluation of dogs with osteosarcoma. J Am Vet Med Assoc 1990, 196:1483-1486.
150. Berg J, Lamb CR, O'Callaghan MW Bone scintigraphy in the initial evaluation of 70 dogs with primary bone tumors. J Am Vet Med Assoc 1990, 196:917-920.
151. Parchman MB, Flanders JA, Erb HN Nuclear medical bone imaging and targeted radiography for evaluation of skeletal neoplasms in 23 dogs. Vet Surg 1989, 18:454-458.
152. Jankowski MK, Steyn PF, Lana SE, et al. Nuclear scanning with 99m-Tc-HDP for the initial evaluation of osseous metastasis in canine osteosarcoma. Vet Comp Oncol 2003, 1:152-158.
153. Enneking WF Staging of musculoskeletal neoplasms. Current concepts of diagnosis and treatment of bone and soft tissue tumors 1964, Springer-Verlag, New York. W.F. Enneking (Ed.).
154. Lamb CR, Berg J, Bengston AE Preoperative measurement of canine primary bone tumors, using radiography and bone scintigraphy. J Am Vet Med Assoc 1990, 196:1474-1478.
155. Leibman N, Kuntz CA, Steyn P, et al. Accuracy of radiography, nuclear scintigraphy and histopathology for determining the proximal extent of distal radial osteosarcoma in dogs. Vet Surg 2001, 30:240-245.
156. Davis GJ, Kapatkin AS, Craig LE, et al. Comparison of radiography, computed tomography and magnetic resonance imaging for evaluation of appendicular osteosarcoma in dogs. J Am Vet Med Assoc 2002, 220:1171-1176.
157. Wallack ST, Wisner ER, Werner JA, et al. Accuracy of magnetic resonance imaging for estimating intramedullary osteosarcoma extent in pre-operative planning of canine limb-salvage procedures. Vet Radiol Ultrasound 2002, 43:432-441.
158. Schwarz PD, Withrow SJ, Curtis CR, et al. Mandibular resection as a treatment for oral cancer in 81 dogs. J Am Anim Hosp Assoc 1991, 27:601-610.
159. White RAS Mandibulectomy and maxillectomy in the dog: Long term survival in 100 cases. J Small Anim Pract 1991, 32:69-74.
160. Kosovsky JK, Matthiesen DT, Manfra-Marretta S, et al. Results of partial mandibulectomy in the treatment of oral tumors in 142 dogs. Vet Surg 1991, 20:397-401.
161. Wallace J, Matthiesen DT, Patnaik AK Hemimaxillectomy for the treatment of oral tumors in 69 dogs. Vet Surg 1992, 21:337-341.
162. Schwarz PD, Withrow SJ, Curtis CR, et al. Partial Maxillary resection as a treatment for oral cancer in 61 dogs. J Am Anim Hosp Assoc 1991, 27:617-624.
163. Hardy WD, Brodey RS, Riser WH Osteosarcoma of the canine skull. J Am Vet Radiol Soc 1967, 8:5-9.
164. Hendrix DV, Gelatt KN Diagnosis, treatment and outcome of orbital neoplasia in dogs: a retrospective study of 44 cases. J Small Anim Pract 2000, 41:105-108.
165. Duffaud F, Digue L, Baciuchka-Palmaro M, et al. Osteosarcomas of flat bones in adolescents and adults. Cancer 2000, 88:324-332.
166. Duffaud F, Digue L, Baciuchka-Palmaro M, et al. Osteosarcomas of flat bones in adolescents and adults. Cancer 2000, 88:324-332.
167. Matthiesen DT, Clark GN, Orsher RJ, et al. En bloc resection of primary rib tumors in 40 dogs. Vet Surg 1992, 21:201-204.
168. V.C.O.G: Retrospective study of 26 primary tumors of the osseous thoracic wall in dogs. J Am Anim Hosp Assoc 1993, 29:68-72.
169. Pirkey-Ehrhart N, Withrow SJ, Straw RC, et al. Primary rib tumors in 54 dogs. J Am Anim Hosp Assoc 1995, 31:65-69.
170. Baines SJ, Lewis S, White RA Primary thoracic wall tumours of mesenchymal origin in dogs: a retrospective study of 46 cases. Vet Rec 2002, 150:335-339.
171. Hammer AS, Weeren FR, Weisbrode SE, et al. Prognostic factors in dogs with osteosarcomas of the flat or irregular bones. J Am Anim Hosp Assoc 1995, 31:321-326.
172. Trout NJ, Pavletic MM, Kraus KH Partial scapulectomy for management of sarcomas in three dogs and two cats. J Am Vet Med Assoc 1995, 207:585-587.
173. Morgan EP, Ackerman N, Bailey CS, et al. Vertebral tumors in the dog: a clinical, radiologic, and pathologic study of 61 primary and secondary lesions. Vet Radiol 1980, 21:197-212.
174. Dernell WS, Van Vechten BJ, Straw RC, et al. Outcome following treatment for vertebral tumors in 20 dogs (1986-1995). J Am Anim Hosp Assoc 2000, 36:245-251.
175. Cooley DM, Waters DJ Skeletal neoplasms of small dogs: a retrospective study and literature review. J Am Anim Hosp Assoc 1997, 33:11-23.
176. Kuntz CA, Asselin TL, Dernell WS, et al. Limb salvage surgery for osteosarcoma of the proximal humerus: outcome in 17 dogs. Vet Surg 1998, 27:417-422.
177. Bergman PJ, MacEwen EG, Kurzman ID, et al. Amputation and carboplatin for treatment of dogs with osteosarcoma: 48 cases (1991-1993), J. Vet Int Med 1996, 10:76-81.
178. Brostrom LA, Strander H, Nilsonne U Survival in osteosarcoma in relation to tumor size and location. Clin Orthop 1982, 167:250-254.
179. Erhart N, Dernell WS, Hoffmann WE, et al. Prognostic importance of alkaline phosphatase activity in serum from dogs with appendicular osteosarcoma: 75 cases (1990-1996). J Am Vet Med Assoc 1998, 213:1002-1006.
180. Garzotto CK, Berg J, Hoffmann WE, et al. Prognostic significance of serum alkaline phosphatase activity in canine appendicular osteosarcoma. J Vet Intern Med 2000, 14:587-592.
181. Vail DM, Kurzman ID, Glawe PC, et al. STEALTH liposome-encapsulated cisplatin (SPI-77) versus carboplatin as adjuvant therapy for spontaneously arising osteosarcoma (OSA) in the dog: a randomized multicenter clinical trial. Cancer Chemoth Pharmacol 2002, 50:131-136.
182. Wunder JS, Eppert K, Burrow SR, et al. Co-amplification and overexpression of CDK4, SAS and MDM2 occurs frequently in human parosteal osteosarcomas. Oncogene 1999, 18:783-788.
183. Asada N, Tsuchiya H, Tomita K De novo deletions of p53 gene and wild-type p53 correlate with acquired cisplatin-resistance in human osteosarcoma OST cell line. Anticancer Res 1999, 19:5131-5137.
184. Wunder JS, Bull SB, Aneliunas V, et al. MDR1 gene expression and outcome in osteosarcoma: a prospective, multicenter study. J Clin Oncol 2000, 18:2685-2694.
185. Terek RM, Schwartz GK, Devaney K, et al. Chemotherapy and p-glycoprotein expression in chondrosarcoma. J Orthop Res 1998, 16:585-590.
186. Hornicek FJ, Gebhart MC, Wolfe MW, et al. P-glycoprotein levels predict poor outcome in patients with osteosarcoma. Clin Orthop Relat Res 2000, 373:11-17.
187. Trieb K, Lechleitner Lang S, et al. Heat shock protein 72 expression in osteosarcomas correlates with good response to neoadjuvant chemotherapy. Hum Pathol 1998, 29:1050-1055.
188. Larue SM, Fox MH, Withrow SJ, et al. Impact of heterogeneity in the predictive value of kinetic parameters in canine osteosarcoma. Cancer Res 1994, 54:3916-3921.
189. Carberry CA, Harvey HJ Owner satisfaction with limb amputation is dogs and cats. J Am Anim Hosp Assoc 1987, 23:227-232.
190. Withrow SJ, Hirsch VM Owner's response to amputation of a pet's leg. Vet Med Small Anim Clin 1979, 10:332-334.
191. Vasseur P Limb preservation in dogs with primary bone tumors. Vet Clin North Am 1987, 17:889-993.
192. Berg J, Weinstein MJ, Schelling SH, et al. Treatment of dogs with osteosarcoma by administration of cisplatin after amputation or limb-sparing surgery: 22 cases (1987-1990). J Am Vet Med Assoc 1992, 200:2005-2008.
193. LaRue SM, Withrow SJ, Powers BE, et al. Limb sparing treatment for osteosarcoma in dogs. J Am Vet Med Assoc 1989, 195:1734-1744.
194. Thrall DE, Withrow SJ, Powers BE, et al. Radiotherapy prior to cortical allograft limb sparing in dogs with osteosarcoma: a dose response assay. Int J Rad Onc Biol Phys 1990, 18:1354-1357.
195. Withrow SJ, Thrall DE, Straw RC, et al. Intra-arterial cisplatin with or without radiation in limbsparing for canine osteosarcoma. Cancer 1993, 71:2484-2490.
196. Straw RC, Withrow SJ Limb-sparing surgery versus amputation for dogs with bone tumors. Vet Clin North Am 1996, 26:135-143.
197. O'Brien MG, Withrow SJ, Straw RC Recent advances in the treatment of canine appendicular osteosarcoma. Comp Contin Educ Pract Vet 1993, 15:613-616.
198. Liptak JM, Dernell WS, Straw RC, et al. Intercalary bone grafts for joint and limb preservation in 17 dogs with high grade malignant tumors of the diaphysis. Vet Surg 2004, 33:457-467.
199. Meyer MS, Spanier SS, Moser M, et al. Evaluating marrow margins for resection of osteosarcoma. A modern approach. Clin Orthop Relat Res 1999, 363:170-175.
200. Tomford WW, Doppelt SH, Mankin HJ 1983 bone banking procedures. Clin Orthop Rel Res 1983, 174:15-21.
201. Morello E, Buracco P, Martano M, et al. Bone allografts and adjuvant cisplatin for the treatment of canine appendicular osteosarcoma in 18 dogs. J Small Anim Pract 2001, 42:61-66.
202. Straw RC, Powers BE, Withrow SJ, et al. The effect of intramedullary polymethylmethacrylate on healing of intercalary cortical allografts in a canine model. J Orthop Res 1992, 10:434-439.
203. Kirpensteijn J, Steinheimer D, Park RD, et al. Comparison of cemented and non-cemented allografts for limb sparing procedures in dogs with osteosarcoma of the distal radius. Vet Comp Orthop Traumatol 1998, 11:178-184.
204. Dernell WS, Withrow SJ, Straw RC, et al. Clinical response to antibiotic impregnated polymethyl methacrylate bead implantation of dogs with severe infections after limb sparing with allograft replacement-18 cases (1994-1996). Vet Comp Orthop Traumatol 1998, 11:94-99.
205. Liptak JM, Pluhar GE, Dernell WS, et al. Limb-sparing surgery in a dog with osteosarcoma of the proximal femur. Vet Surg 2005, 34:71-77.
206. Morello E, Vasconi E, Martano M, et al. Pasteurized tumoral autograft and adjuvant chemotherapy for the treatment of canine distal radial osteosarcoma: 13 cases. Vet Surg 2003, 32:539-544.
207. Buracco P, Morello E, Martano M, et al. Pasteurized tumoral autograft as a novel procedure for limb sparing in the dog: a clinical report. Vet Surg 2002, 31:525-532.
208. Ehrhart N Longitudinal bone transport for treatment of primary bone tumors in dogs: technique description and outcome in 9 dogs. Vet Surg 2005, 34:24-34.
209. Tommassini M, Ehrhart N, Ferretti A, et al. Bone transport osteogenesis for limb salvage following resection of primary bone tumors: experience with 6 cases (1991-1996). Vet Comp Orthop Trauma 2000, 23:43-51.
210. Ehrhart N, Eurell JE, Tomassini M, et al. The effect of cisplatin chemotherapy on regenerate bone formation. Am J Vet Res 2002, 63:703-711.
211. Rovesti GL, Bascucci M, Schmidt K, et al. Limb sparing using a double bone-transport technique for treatment of a distal tibial osteosarcoma in a dog. Vet Surg 2002, 31:70-77.
212. Seguin B, Walsh PJ, Mason DR, et al. Use of an ipsilateral vascularized ulnar transposition autograft for limb-sparing surgery of the distal radius in dogs: an anatomic and clinical study. Vet Surg 2003, 32:69-79.
213. Pooya HA, Seguin B, Mason DR, et al. Biomechanical comparison of cortical radial graft versus ulnar transposition graft limb-sparing techniques for the distal radial site in dogs. Vet Surg 2004, 33:301-308.
214. Liptak JM, Dernell WS, LaScelles BDX, et al. Intraoperative extracorporeal irradiation for limb sparing in 13 dogs. Vet Surg 2004, 33:446-456.
215. Huber DJ, Withrow SJ, Larue SM, et al. Limb sparing with intraoperative radiation for bone sarcomas. Vet Surg 2000, 29:464.
216. Straw RC, Withrow SJ, Douple EB, et al. The effects of cis-diamminedichloroplatinum II released from D,L,-polylactic acid implanted adjacent to cortical allografts in dogs. J Orthop Res 1994, 12:871-877.
217. Withrow SJ, Liptak J, Straw RC, et al. Biodegradable cisplatin polymer in limb-sparing surgery for canine osteosarcoma. Ann Surg Oncol 2004, 11:705-713.
218. Cavaliere R, Di Filippo F, Santori L, et al. Role of hyperthermic perfusion in the treatment of limb osteogenix sarcoma. Oncol 1987, 44:1-5.
219. Van Ginkel RJ, Hoekstra HJ, Meutstege FJ, et al. Hyperthermic isolated regional perfusion with cisplatin in the local treatment of spontaneous canine osteosarcoma: assessment of short-term effects. J Surg Oncol 1995, 59:169-176.
220. Zachos TA, Aiken SW, DiResta GR, et al. Interstitial fluid pressure and blood flow in canine osteosarcoma and other tumors. Clin Orthop Relat Res 2001, 385:230-236.
221. Powers BE, Withrow SJ, Thrall DE, et al. Percent tumor necrosis as a predictor of treatment response in canine osteosarcoma. Cancer 1991, 67:126-134.
222. Lascelles BDX, Dernell WS, Correa MT et al: Improved survival associated with postoperative wound infection in dogs treated with limb-salvage surgery for osteosarcoma, Ann Surg Oncol, in press.
223. Straw RC, Withrow SJ, Powers BE Partial or total hemipelvectomy in the management of sarcomas in seven dogs and two cats. Vet Surg 1992, 21:183-188.
224. Kirpensteijn J, Straw RC, Pardo AD, et al. Partial and total scapulectomy in the dog. J Am Anim Hosp Assoc 1994, 30:313-319.
225. Dernell WS, Schwarz PD, Withrow SJ Mandibulectomy. Current techniques in small animal surgery 1996, 132-143. Lea & Febiger, Philadelphia. M.J. Bojrab (Ed.).
226. Dernell WS, Schwarz PD, Withrow SJ Maxillectomy and premaxillectomy. Current techniques in small animal surgery 1996, 124-132. Lea & Febiger, Philadelphia. M.J. Bojrab (Ed.).
227. Lascelles BDX, Thomson MJ, Dernell WS, et al. Combined dorsolateral and intraoral approach for the resection of tumors of the maxilla in the dog. J Am Anim Hosp Assoc 2003, 39:294-305.
228. Fox LE, Geoghegan SL, Davis LH, et al. Owner satisfaction with partial mandibulectomy and maxillectomy for treatment of oral tumors in 27 dogs. J Am Anim Hosp Assoc 1997, 33:25-31.
229. O'Brien MG, Withrow SJ, Straw RC, et al. Total and partial orbitectomy for the treatment of periorbital tumors in 23 dogs and 6 cats. Vet Surg 1996, 25:471-479.
230. Straw RC, Withrow SJ, Powers BE Primary Osteosarcoma of the ulna in 12 dogs. J Am Anim Hosp Assoc 1991, 27:323-326.
231. Walter WS, Dernell SM, LaRue SE, et al. Curative-intent radiation therapy as a treatment modality for appendicular and axial osteosarcoma: a preliminary retrospective evaluation of 14 dogs with the disease. Vet Comp Oncol 2005, 3:1-7.
232. Oya N, Kokubo M, Mizawaki T, et al. Definitive intraoperative very high-dose radiotherapy for localized osteosarcoma in the extremities. Int J Radiat Oncol Biol Phys 2001, 51:87-93.
233. Farese JP, Milner R, Thompson MS, et al. Stereotactic radiosurgery for treatment of osteosarcomas involving the distal portions of the limbs in dogs. J Am Vet Med Assoc 2004, 225:1548. 1567-1572.
234. Forrest LJ, Mackie TR, Ruchala K, et al. The utility of megavoltage computed tomography images from a helical tomotherapy system for setup verification purposes. Int J Radiation Oncology Biol Phys 2004, 60:1639-1644.
235. Anderson PM, Wiseman GA, Dispenzieri A, et al. High-dose samarium-153 ethylene diamine tetramethylene phosphonate: low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastases. J Clin Oncol 2002, 20:189-196.
236. Milner RJ, Dormehl I, Louw WK, et al. Targeted radiotherapy with Sm-153-EDTMP in nine cases of canine primary bone tumours. J S Afr Vet Assoc 1998, 69:12-17.
237. Aas M, Moe L, Gamlem H. Internal radionuclide therapy of primary osteosarcoma in dogs, using 153Sm-ethylene-diamino-tetramethylene-phosphonate (EDTMP). Clin Cancer Res 1999, 5(10 Suppl):3148s-3152s.
238. Lattimer JC, Corwin LA, Stapleton J, et al. Clinical and clinicopathologic response of canine bone tumor patients to treatment with samarium-153-EDTMP. J Nucl Med 1990, 31:1316-1325.
239. Shapiro W, Fossum TW, Kitchell BE Use of cisplatin for the treatment of appendicular osteosarcoma in dogs. J Am Vet Med Assoc 1988, 4:507-511.
240. Thompson JP, Fugent MJ Evaluation of survival times after limb amputation, with and without subsequent administration of cisplatin, for treatment of osteosarcoma in dogs: 30 cases (1979-1990). J Am Vet Med Assoc 1992, 200:531-533.
241. Kraegel SA, Madewell BR, Simonson E Osteogenic sarcoma and cisplatin chemotherapy in dogs: 16 cases (1986-1989). J Am Vet Med Assoc 1991, 199:1057-1059.
242. Ayala AG, Raymond AK, Jaffe N The pathologist's role in the diagnosis and treatment of osteosarcoma in children. Hum Pathol 1984, 15:258-266.
243. Bacci G, Springfield D, Campanner R Neoadjuvant chemotherapy for osteosarcoma of the extremity. Clin Orthop Rel Res 1987, 24:268-276.
244. Chuang VP, Wallace S, Benjamin RS The therapy of osteosarcoma by intra-arterial cis-platinum and limb preservation. Cardiovasc Intervent Radiol 1981, 4:229-235.
245. Jaffe N, Knapp J, Chuang VP Osteosarcoma: intra-arterial treatment of the primary tumor with cis-diamine-dichloroplatinum-II(CDP): angiographic, pathologic and pharmacologic studies. Cancer 1983, 51:402-407.
246. Winkler K, Beron G, Delling G: Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response J Clin Oncol 6:329-337.
247. Forrester SD, Fallin EA, Saunders GK, et al. Prevention of cisplatin-induced nephrotoxicosis in dogs, using hypertonic saline solution as the vehicle of administration. Am J Vet Res 1993, 54:2175-2178.
248. Ogilvie GK, Krawiec DR, Gelberg HB Evaluation of a short-term saline diuresis protocol for the administration of cisplatin. Am J Vet Res 1988, 49:1076-1078.
249. Hahn KA, Legendre AM, Talbott JR The frequency of micronuclei in lymphocytes of dogs with osteosarcoma: a predictive variable for tumor response during cisplatin chemotherapy. Cancer Epidemiol Biomarkers Prev 1996, 5:653-656.
250. Berg J, Weinstein MJ, Springfield DS, et al. Response of osteosarcoma in the dog to surgery and chemotherapy with doxorubicin. J Am Vet Med Assoc 1995, 206:1555-1560.
251. Curt AH, Grygiel JJ, Corden BJ, et al. A phase I pharmacokinetic study of diammine cyclobutane-dicarboxylatoplatinum (NSC 241240). Cancer Res 1983, 43:4470-4473.
252. Calvert AH, Harland SJ, Newell DL, et al. Phase I studies with carboplatin at the Royal Marsden Hospital. Cancer Treat Rev 1985, 12(suppl A):51-57.
253. Koeller JM, Trump DL, Tutsch KD, et al. Phase I clinical trial and pharmacokinetics of carboplatin (NSC 241240) by single monthly 30-minute infusion. Cancer 1986, 57:222-225.
254. Canetta R, Bragman K, Smaldone L et al: Carboplatin: current status and future prospects Cancer Treat Rev 15:17-32.
255. Canetta R, Franks C, Smaldone L, et al. Clinical status of carboplatin. Oncology-Huntington 1987, 1:61-69.
256. Kirpensteijn J, Teske E, Kik M, et al. Lobaplatin as an adjuvant chemotherapy to surgery in canine appendicular osteosarcoma: a phase II evaluation. Anticancer Res 2002, 22:2765-2770.
257. Madewell BR, Leighton RC, Theilen GH Amputation and doxorubicin for treatment of canine and feline osteogenic sarcoma. Eur J Cancer 1978, 4:287-293.
258. Mealey KL, Barhoumi R, Rogers J, et al. Doxorubicin induced expression of P-glycoprotein in a canine osteosarcoma cell line. Cancer Lett 1998, 126:187-192.
259. Moretti JL, Caglar M, Boaziz C, et al. Sequential functional imaging with technetium-99m-hexakis-2-mothoisobutylisonitrile and indium-111-octreotide: can we predict the response to chemotherapy in small cell lung cancer?. Eur J Nucl Med 1995, 22:177-180.
260. Rao VV, Chui ML, Kronauge JF, et al. Expression of recombinant human multidrug resistance p-glycoprotein in insect cells confers decreased accumulation of technitium-99m-sestamibi. J Nucl Med 1994, 35:510-514.
261. Cagliero E, Ferracini R, Morello E, et al. Reversal of multidrug-resistance using Valspodar (PSC 833) and doxorubicin in osteosarcoma. Oncol Rep 2004, 12:1023-1031.
262. Chun R, Kurzman ID, Couto G, et al. Cisplatin and doxorubicin combination chemotherapy for the treatment of canine osteosarcoma: preliminary findings. J Vet Int Med 2000, 14:495-498.
263. Berg J, Gebhard MC, Rand WM Effect of timing on postoperative chemotherapy on survival of dogs with osteosarcoma. Cancer 1997, 79:1343-1350.
264. DeRegis CJ, Moore AS, Rand WM, et al. Cisplatin and doxorubicin toxicosis in dogs with osteosarcoma. J Vet Intern Med 2003, 17:668-673.
265. Mauldin GN, Matus RE, Withrow SJ Canine osteosarcoma treatment by amputation versus amputation and adjuvant chemotherapy using doxorubicin and cisplatin. J Vet Int Med 1988, 2:177-180.
266. Kent MS, Strom A, London CA, et al. Alternating carboplatin and doxorubicin as adjunctive chemotherapy to amputation or limb-sparing surgery in the treatment of appendicular osteosarcoma in dogs. J Vet Intern Med 2004, 18:540-544.
267. Bailey D, Erb H, Williams L, et al. Carboplatin and doxorubicin combination chemotherapy for the treatment of appendicular osteosarcoma in the dog. J Vet Intern Med 2003, 17:199-205.
268. Withrow SJ, Straw RC, Brekke JH, et al. Slow release adjuvant cisplatin for the treatment of metastatic canine osteosarcoma. Eur J Musculoskel Res 1995, 4:105-110.
269. Mehl ML, Sequin B, Dernell WS, et al. Survival analysis of one versus two treatments of local delivery cisplatin in a biodegradable polymer for canine osteosarcoma. J Vet Comp Oncology 2005, 3:81-86.
270. Kurzman ID, Shi FS, Vail DM, et al. In vitro and in vivo enhancement of canine pulmonary alveolar macrophage cytotoxic activity against canine osteosarcoma cells. Cancer Biotherapy Radiopharmaceuticals 1999, 14:121-128.
271. Shi F, MacEwen EG, Kurzman ID In vitro and in vivo effect of doxorubicin combined with liposome-encapsulated muramyl tripeptideon canine monocyte activation. Cancer Res 1993, 53:3986-3995.
272. Vail DM, MacEwen EG, Kurzman ID, et al. Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine (L-MTP-PE) immunotherapy for splenic hemangiosarcoma in the dog: A randomized multi-institutional clinical trial. Clin Cancer Res 1995, 1:1165-1170.
273. Klinerman ES, Meyers PA, Raymond AK, et al. Combination therapy with ifosfamide and liposome-encapsulated muramyl tripeptide: tolerability, toxicity, and immune stimulation. J Immunother Emphasis Tumor Immunol 1995, 17:181-193.
274. MacEwen EG, Kurzmann ID, Rosenthal RC Therapy for osteosarcoma in dogs with intravenous injection of liposome-encapsulated muramyl tripeptide. J Natl Cancer Inst 1989, 81:935-958.
275. Kurzman ID, MacEwen EG, Rosenthal RC, et al. Adjuvant therapy for osteosarcoma in dogs: Results of randomized clinical trials using combined liposome-encapsulated muramyl tripeptide and cisplatin. Clin Cancer Res 1995, 1:1595-1601.
276. Meyers PA, Schwartz CL, Krailo M, et al. Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin and high-dose methotrexate. J Clin Oncol 2005, 23:2004-2011.
277. Romet-Lemonne J-L, Mills B, Fridman WH, et al. Prospectively planned analysis of data from a phase III study of liposomal muramyltripeptide phosphatidylethanolamine in the treatment of osteosarcoma, Letter. J Clin Oncol 2005, 23:6437-6439.
278. Khanna C, Prehn J, Hayden D, et al. A randomized controlled trial of octreotide pamoate long-acting release and carboplatin versus carboplatin alone in dogs with naturally occurring osteosarcoma: evaluation of insulin-like growth factor suppression and chemotherapy. Clin Cancer Res 2002, 8:2406-2412.
279. Fan TM, de Lorimier LP, Charney SC, et al. Evaluation of intravenous pamidronate administration in 33 cancer-bearing dogs with primary or secondary bone involvement. J Vet Intern Med 2005, 19:74-80.
280. Hahn KA, Legendre AM, Schuller HM Amputation and dexniguldipine as treatment for canine appendicular osteosarcoma. J Cancer Res Clin Oncol 1997, 123:34-128.
281. Wolfesberger B, Walter I, Hoelzl C et al: Antineoplastic effect of the cycloosygenase inhibitor meloxicam on canine osteosarcoma cells, Res Vet Sci: Epub ahead of print, 2005.
282. Farese JP, Fox LE, Detrisac CJ, et al. Effect of thalidomide on growth and metastasis of canine osteosarcoma cells after zenotransplantation in athymic mice. Am J Vet Res 2004, 65:659-664.
283. Downey RJ Surgical treatment of pulmonary metastases. Surg Oncol Clin North Am 1999, 8:341-354.
284. O'Brien MG, Straw RC, Withrow SJ, et al. Resection of pulmonary metastases in canine osteosarcoma: 36 cases (1983-1992). Vet Surg 1993, 22:105-109.
285. Ogilvie GK, Straw RC, Jameson VJ, et al. Evaluation of single agent chemotherapy for the treatment of clinically evident osteosarcoma metastasis in dogs: (1987-1991). J Am Vet Med Assoc 1993, 202:304-306.
286. Poirier VJ, Hershey AE, Burgess KE, et al. Efficacy and toxicity of paclitaxel (Taxol) for the treatment of canine malignant tumors. J Vet Intern Med 2004, 18:219-222.
287. Koshkina NV, Agoulnik IY, Melton SL, et al. Biodistribution and pharmacokinetics of aerosol and intravenously administered DNA-polyethyleneimine complexes: optimization of pulmonary delivery and retention. Mol Ther 2003, 8:249-254.
288. Hershey AE, Kurzman ID, Forrest LJ, et al. Inhalation chemotherapy for macroscopic primary or metastatic lung tumors: proof of principle using dogs with spontaneously occurring tumors as a model. Clin Cancer Res 1999, 5:2653-2659.
289. Khanna C, Vail DM Targeting the lung: preclinical and comparative evaluation of anticancer aerosols in dogs with naturally occurring cancers. Current Cancer Drug Targets 2003, 3:265-273.
290. Koshkina NV, Kleinerman ES Aerosol gemcitabine inhibits the growth of primary osteosarcoma and osteosarcoma lung metastases. Int J Cancer 2005, 116:458-463.
291. Poulaki V, Mitsiades CS, Mitsiades N The role of Fas and FasL as mediators of anticancer chemotherapy. Drug Resist Update 2001, 4:233-242.
292. Micheau O, Solary E, Hammann A, et al. Sensitization of cancer cells treated with cytotoxic drugs to fas-mediated cytotoxicity. J Natl Cancer Inst 1997, 89:783-789.
293. Khanna C, Anderson PM, Hasz DE, et al. Interleukin-2 liposome inhalation therapy is safe and effective for dogs with spontaneous osteosarcoma metastases. Cancer 1997, 79:1409-1421.
294. Khanna C, Hasz DE, Klausner JS, et al. Aerosol delivery of interleukin 2 liposomes is nontoxic and biologically effective: canine studies. Clin Cancer Res 1996, 2:721-734.
295. Dow S, Elmslie R, Kurzman I, et al. Phase I study of liposome-DNA complexes encoding the interleukin-2 gene in dogs with osteosarcoma lung metastases. Hum Gene Ther 2005, 16:937-946.
296. McEntee MC, Page RL, Novotney CA, et al. Palliative radiotherapy for canine appendicular osteosarcoma. Vet Radiol Ultrasound 1993, 34:367-370.
297. Ramirez O, Dodge RK, Page RL, et al. Palliative radiotherapy of appendicular osteosarcoma in 95 dogs. Vet Radiol Ultrasound 1999, 40:517-522.
298. Mueller F, Poirier V, Melzer K, et al. Palliative radiotherapy with electrons of appendicular osteosarcoma in 54 dogs. In Vivo 2005, 19:713-716.
299. Green EM, Adams WM, Forrest LJ Four fraction palliative radiotherapy for osteosarcoma in 24 dogs. J Am Anim Hosp Assoc 2002, 38:445-451.
300. Heidner GL, Page RL, McEntee MC, et al. Treatment of canine appendicular osteosarcoma using cobalt 60 radiation and intraarterial cisplatin. J Vet Intern Med 1991, 5:313-316.
301. Sze WM, Shelley MD, Held I, et al. Palliation of metastatic bone pain single fraction versus multifraction radiotherapy-a systematic review of randomised trials. Clinical Oncol 2003, 15:345-352.
302. Wu JS, Wong R, Johnston M, et al. Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases. Int J Radiation Oncology Biol Phys 2003, 55:594-605.
303. Ben-Josef E, Shamsa F, Youssef E, et al. External beam radiotherapy for painful osseous metastases: pooled data dose response analysis. Int J Radiat Oncol Biol Phys 1999, 45:715-719.
304. Goeckeler WF, Stoneburner LK, Kasi LP, et al. Analysis of urine samples from metastatic bone cancer patients administered 153Sm-EDTMP. Nucl Med Biol 1993, 20:657-661.
305. Holmes RA Radiopharmaceuticals in clinical trials. Semin Oncol 1993, 20(3 Suppl 2):22-26.
306. Lattimer JC, Corwin LA, Stapleton J, et al. Clinical and clinicopathologic effects of samarium-153-EDTMP administered intravenously to normal beagle dogs. J Nucl Med 1990, 31:586-593.
307. Knapp DW, Richardson RC, Chan TCK, et al. Piroxicam therapy in 34 dogs with transitional cell carcinoma of the urinary bladder. J Vet Int Med 1994, 8:273-278.
308. Rogers MJ, Watts DJ, Russell RGG Overview of biphosphonates. Cancer 1997, 80:1652-1660.
309. Lipton A, Theriault RL, Hortobagyi GN, et al. Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases. Cancer 2000, 88:1082-1090.
310. Tomlin JL, Sturgeon C, Pead MJ, et al. Use of the bisphosphonate drug alendronate for palliative management of osteosarcoma in two dogs. Vet Record 2000, 147:129-132.
311. Vail DM, Thamm DH Spontaneously occurring tumors in companion animals as models for drug development. Anticancer drug development guide 2004, Humana Press, Totowa, New Jersey. ed 2. B.A. Teisher (Ed.).
312. Mankin HJ, Hornicek FJ, Rosenberg AE, et al. Survival data for 648 patients with osteosarcoma treated at one institution. Clin Orthop Relat Res 2004, 429:286-291.
313. Wilkins RM, Cullen JW, Camozzi AB, et al. Improved survival in primary nonmetastatic pediatric osteosarcoma of the extremity. Clin Orthop Rel Res 2005, 438:128-136.
314. Bacci G, Ferrari S, Bertoni F, et al. Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the Instituto Orthopedico Rizzoli according to the Instituto Orthopedico Rizzoli/osteosarcoma-2 protocol: an updated report. J Clin Oncol 2000, 18:4016-4027.
315. Okada K, Krishnan-Unni K, Swee RG, et al. High grade surface osteosarcoma: a clinicopathologic study of 46 cases. Cancer 1999, 85:1044-1054.
316. Banks WC Parosteal osteosarcoma in a dog and a cat. J Am Vet Med Assoc 1971, 158:1412-1415.
317. Withrow SJ, Doige CE En block resection of a juxtacortical and three intra-osseous osteosarcomas of the zygomatic arch in dogs. J Am Anim Hosp Assoc 1980, 867:872.
318. Moores AP, Beck AL, Baker JF High-grade surface osteosarcoma in a dog. J Small Anim Pract 2003, 44:218-220.
319. Brodey RS, Riser WH, van der Heul RO Canine skeletal chondrosarcoma: a clinicopathological study of 35 cases. J Am Vet Med Assoc 1974, 165:68-78.
320. Brodey RS, Riser WH Canine osteosarcoma: a clinicopathologic study of 194 cases. Clin Orthop 1969, 62:54-64.
321. Sylvestre AM, Brash ML, Atilola MAO, et al. A case series of 25 dogs with chondrosarcoma. Vet Comp Orthop Traumatol 1992, 5:13-17.
322. Doige CE Multiple cartilaginous exostosis in dogs. Vet Pathol 1987, 24:276-278.
323. Doige CE, Pharr JW, Withrow SJ Chondrosarcoma arising in multiple cartilaginous exostosis in a dog. J Am Anim Hosp Assoc 1978, 14:605-611.
324. Popovitch CA, Weinstein MJ, Goldschmidt MH, et al. Chondrosarcoma: a retrospective study of 97 dogs (1987-1990). J Am Anim Hosp Assoc 1994, 30:81-85.
325. Southerland EM, Miller RT, Jones CL Primary right atrial chondrosarcoma in a dog. J Am Vet Med Assoc 1993, 203:1697-1701.
326. Anderson WI, Carberry CA, King JM, et al. Primary aortic chondrosarcoma in a dog. Vet Pathol 1988, 25:180-181.
327. Patnaik AK, Mattiesen DT, Zawie DA Two cases of canine penile neoplasm: squamous cell carcinoma and mesenchymal chondrosarcoma. J Am Anim Hosp Assoc 1988, 24:403-406.
328. Flanders JA, Castleman W, Carberry CA, et al. Laryngeal chondrosarcoma in a dog. J Am Vet Med Assoc 1987, 190:68-70.
329. Aron DN, DeVries R, Short CE Primary tracheal chondrosarcoma in a dog: a case report with description of surgical and anesthetic techniques. J Am Anim Hosp Assoc 1980, 16:31-37.
330. Weller RE, Dagle GE, Perry RL, et al. Primary pulmonary chondrosarcoma in a dog. Cornell Vet 1992, 82:447-452.
331. Greenlee PG, Lui SK Chondrosarcoma of the mitral leaflet in a dog. Vet Pathol 1984, 21:540-542.
332. Lana SA, Dernell WS, LaRue SM, et al. Slow release cisplatin combined with radiation for the treatment of canine nasal tumors. Vet Radiol 1997, 38:474-478.
333. Montgomery RD, Henderson RA, Powers BE, et al. Retrospective study of 26 primary thoracic wall tumors in dogs. J Am Anim Hosp Assoc 1993, 29:68-72.
334. Bjornsson J, McLeod RA, Krishnan-Unni K, et al. Primary chondrosarcoma of long bones and limb girdles. Cancer 1998, 83:2105-2119.
335. Hammer AS, Couto CG, Filppi J, et al. Efficacy and toxicity of VAC chemotherapy (vincristine, doxorubicin, and cyclophosphamide) in dogs with hemangiosarcoma. J Vet Int Med 1991, 5:160-166.
336. Ogilvie GK, Powers BE, Mallinckrodt CH, et al. Surgery and doxorubicin in dogs with hemangiosarcoma. J Vet Int Med 1996, 10:379-384.
337. Wesselhoeft Ablin L, Berg J, Schelling SH Fibrosarcoma in the canine appendicular skeleton. J Am Anim Hosp Assoc 1991, 27:303-309.
338. Straw RC, LeCouteur RA, Powers BE, et al. Multilobular osteochondrosarcoma of the canine skull: sixteen cases. J Am Vet Med Assoc 1989, 195:1764-1769.
339. Dernell WS, Straw RC, Cooper MF, et al. Multilobular osteochondrosarcoma in 39 dogs: 1979-1993. J Am Anim Hosp Assoc 1998, 34:11-18.
340. Banks TA, Straw RC Multilobular osteochondrosarcoma of the hard palate in a dog. Aust Vet J 2004, 82:409-412.
341. Lipsitz D, Levitski RE, Berry WL Magnetic resonance imaging features of multilobular osteochondrosarcoma in 3 dogs. Vet Radiol Ultrasound 2001, 42:14-19.
342. Hathcock JT, Newton JC Computed tomographic characteristics of multilobular tumor of bone involving the cranium in 7 dogs and zygomatic arch in 2 dogs. Vet Radiol Ultrasound 2000, 41:214-217.
343. Stoll MR, Roush JK, Moisan PG Multilobular tumour of bone with no abnormalities on plain radiography in a dog. J Small Anim Pract 2001, 42:453-455.
344. Johnson KA, Cooley AJ, Darien DL Zygomatic osteoma with atypical heterogeneity in a dog. J Comp Pathol 1996, 114:199-203.
345. Chester DK Multiple Cartilaginous exostoses in two generations of dogs. J Am Vet Med Assoc 1971, 159:895-897.
346. Gee BR, Doige CE Multiple cartilaginous exostoses in a litter of dogs. J Am Vet Med Assoc 1970, 156:53-59.
347. Prata RG, Carillo JM Nervous system. Textbook of small animal surgery 1985, W.B. Saunders, Philadelphia. D.H. Slatter (Ed.).
348. Hunt GB, Johnson KA What is your diagnosis?. J Am Vet Med Assoc 1991, 199:1071-1072.
349. Pernell RT, Dunstan RW, DeCamp CE Aneurysmal bone cyst in a six-month-old dog. J Am Vet Med Assoc 1992, 201:1897-1899.
350. Biery DN, Goldschmidt M, Riser WH, et al. Bone cysts in the dog. J Am Vet Radiol 1976, 17:202-212.
351. Basher AWP, Doige CE, Presnell KR Subchondral bone cysts in a dog with osteochondrosis. J Am Anim Hosp Assoc 1988, 24:321-326.
352. Schrader SC, Burk Lui S Bone cysts in two dogs and a review of similar cystic bone lesions in the dog. J Am Vet Med Assoc 1983, 182:490-495.
353. Mirra JM Cysts and cyst-like lesions of bone. Bone tumors: clinical, radiographic, and pathologic correlations 1989, Lea & Febiger, Philadelphia. J.M. Mirra, P. Picci, R.H. Gold (Eds.).
354. Grabias S, Mankin H Chondrosarcoma arising in histologically proved unicameral bone cyst. J Bone Joint Surg 1973, 56A:1501-1503.
355. Halliwell WH Tumorlike lesions of bone. Disease mechanisms in small animal surgery 1993, Lea & Febiger, Philadelphia. M.J. Bojrab (Ed.).
356. Pernell RT, Dunstan RW, DeCamp CE Aneurysmal bone cyst in a six-month-old dog. J Am Vet Med Assoc 1992, 201:1897-1899.
357. Dorn CR, Taylor DON, Schneider R Survey of animal neoplasms in Alameda and Contra Costa Counties, California. II. Cancer morbidity in dogs and cats from Alameda County. J Natl Cancer Inst 1968, 40:307-318.
358. Bitetto WV, Patnaik AK, Schrader SC, et al. Osteosarcoma in cats: 22 cases (1974-1984). J Am Vet Med Assoc 1987, 190:91-93.
359. Heldmann E, Anderson MA, Wagner-Mann CC Feline osteosarcoma: 145 cases (1990-1995). J Am Anim Hosp Assoc 2000, 36:518-521.
360. Spugnini EP, Ruslander D, Bartolazzi A Extraskeletal osteosarcoma in a cat. J Am Vet Med Assoc 2001, 219:60-62.
361. Stimson EL, Cook WT, Smith MM, et al. Extraskeletal osteosarcoma in the duodenum of a cat. J Am Anim Hosp Assoc 2000, 36:332-336.
362. Dhaliwal RS, Johnson TO, Kitchell BE Primary extraskeletal hepatic osteosarcoma in a cat. Am Vet Med Assoc 2003, 222:316. 340-342.
363. Turrel JM, Pool RR Primary bone tumors in the cat: a retrospective study of 15 cats and a literature review. Vet Radiol 1982, 23:152-166.
364. Carpenter JL, Andrews LK, Holzworth J Tumors and tumor-like lesions. Diseases of the cat medicine and surgery 1987, W.B. Saunders, Philadelphia. J. Holzworth (Ed.).
365. Berman E, Wright JF What is your diagnosis? [osteosarcoma of tibia and hemangiosarcoma of femur metastatic to lungs in an irradiated cat]. J Am Vet Med Assoc 1973, 162:1065-1066.
366. Pool RR, Carrig CB Multiple cartilaginous exostoses in a cat. Vet Pathol 1972, 9:350-359.
367. Lui S, Dorfman HD, Patnaik AK Primary and secondary bone tumours in the cat. J Small Anim Pract 1974, 15:141-156.
368. Quigley PJ, Leedale AH Tumors involving bone in the domestic cat: a review of fifty-eight cases. Vet Pathol 1983, 20:670-686.
369. Riddle WEJ, Leighton RL Osteochondromatosis in a cat. J Am Vet Med Assoc 1970, 156:1428-1430.